Results 181 to 190 of about 163,907 (339)

Targeted immunotherapies for Graves' thyroidal & orbital diseases. [PDF]

Front Immunol
Lee ACH, Kahaly GJ.
europepmc   +1 more source

Nuclear Factor I‐B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription

Advanced Science, EarlyView.
This study identifies the transcription factor Nuclear Factor I‐B (NFIB) as a key suppressor of liver fibrosis. NFIB expression declines during hepatic stellate cell activation, and its overexpression reduces fibrosis in mice models. The mechanism involves NFIB directly repressing chemokine C─C motif ligand 5 (CCL5), thereby alleviating oxidative ...
Qianqian Chen, Fajuan Rui, Zhiwen Fan, Hongju Yang, Nan Geng, Chenqi Lu, Wenjing Ni, Yue Huan, Junping Shi, Chao Wu, Shengxia Yin, Wei An, Xia Lu, Qianwen Zhao, Jie Li   +14 more
wiley   +1 more source

Corrigendum: 3D-Printed Poly-Caprolactone Scaffolds Modified With Biomimetic Extracellular Matrices for Tarsal Plate Tissue Engineering

Frontiers in Bioengineering and Biotechnology, 2020
Liangbo Chen, Liangbo Chen, Dan Yan, Dan Yan, Nianxuan Wu, Nianxuan Wu, Weijie Zhang, Weijie Zhang, Chenxi Yan, Chenxi Yan, Qinke Yao, Qinke Yao, Christos C. Zouboulis, Hao Sun, Hao Sun, Yao Fu, Yao Fu   +16 more
doaj   +1 more source

Use of Robotic Surgery for the Management of Orbital Diseases: A Comprehensive Review. [PDF]

Medicina (Kaunas)
Nocini R, Marini L, Michelutti L, Zilio C, Troise S, Sembronio S, Dell'Aversana Orabona G, Robiony M, Tel A.   +8 more
europepmc   +1 more source

TRIM38 Suppresses Breast Cancer Progression via Modulating SQSTM1 Ubiquitination and Autophagic Flux

Advanced Science, EarlyView.
TRIM38, an E3 ubiquitin ligase, suppresses breast cancer progression by inhibiting proliferation, migration, and invasion. Downregulated in breast tumor, its loss correlates with poor prognosis. Mechanistically, TRIM38 mediates K63‐linked ubiquitination of SQSTM1/p62 at K420, disrupting SQSTM1‐LC3 interaction and blocking autophagic flux.
Shan Jiang, Lijuan Wang, Dianwen Han, Peng Su, Bing Chen, Wenjing Zhao, Tong Chen, Ning Zhang, Xiaolong Wang, Yiran Liang, Yaming Li, Chen Li, Xi Chen, Dan Luo, Qifeng Yang   +14 more
wiley   +1 more source

Guidelines for standard operation of imaging modalities in orbital diseases (2024). [PDF]

Int J Ophthalmol
Shao Y, Ma JM, Huang XM, Expert Workgroup of Guidelines for the use of imaging equipment in orbital diseases (2024); Ophthalmic Imaging and Intelligent Medicine Branch Chinese Medicine Education Association; Ocular Oncology Committee of the Ophthalmology Branch of the Chinese Medical Doctor Association; Ophthalmology Committee of International Association of Translational Medicine; Chinese Ophthalmic Imaging Study Groups.   +3 more
europepmc   +1 more source

Orbital inflammatory disease management [PDF]

, 2016
Grant H. Moore, Daniel B. Rootman
openalex   +1 more source

Organic Electrochemical Transistors in Tissue‐Interfaced Bioelectronics

Advanced Science, EarlyView.
This article reviews the design, fabrication, and biological application of organic electrochemical transistors (OECTs), emphasizing their potential in tissue‐interfaced bioelectronics. It covers the fundamental principles of OECTs, strategies for enhancing tissue interfacing, and the development of skin‐mounted and implantable systems.
Ruixiang Bai, Zeyu Zhao, Feng Yan
wiley   +1 more source

Clinician's approach for spectrum of orbital diseases: An overview. [PDF]

J Family Med Prim Care
Khan L.
europepmc   +1 more source

Cancer Stem Cells Shift Metabolite Acetyl‐Coenzyme A to Abrogate the Differentiation of CD103+ T Cells

Advanced Science, EarlyView.
Lei et al. demonstrate that cancer stem cells (CSCs) play a pivotal role in impairing the differentiation of CD103+ T cells in patients with non‐small‐cell lung cancer. The key mechanism involves CSC‐derived acetyl‐CoA, which disrupts CD103+ T cell differentiation by sequentially inducing acetylation and ubiquitination of the Blimp‐1 protein. Targeting
Jiaxin Lei, Huiyan Ji, Jing Guo, Mengdi Liu, Danhua Su, Yiran Zheng, Lin Xu, Qinghua Cao, Tao Ren, Jun Gui, Zhenke Wen   +10 more
wiley   +1 more source